Breast Arterial Calcifications as A Predictor of Cardiovascular Risk: A Systematic Review

##plugins.themes.bootstrap3.article.main##

  •   Chelsey Lawson

  •   Patrick Batti

  •   Prerna Singh

  •   Madinah Suleiman Usman

  •   Farah Bashir

  •   Benish Alam

  •   Gideon Asaolu

  •   Shaymaa E. Abdelmalek

  •   B. Marie J. Sayo

  •   Epiniah S. Choga

  •   Tuba Khan

  •   Hammad Zafar

  •   Adewale Mark Adedoyin

  •   Maryam Ahmed

  •   Mohammed Numaan Ahmed

Abstract


Introduction: Breast arterial calcification (BAC) is considered a prediction tool for cardiovascular disease (CVD) screening as it has shown some association. The current systematic review reports the evidence on BAC detected on screening mammography and occurrence risk or likelihood of CVD among women.




Methods: Three databases, including PubMed, Cochrane, and Google Scholar, were searched by three independent reviewers.




Results: A total of 34,887 patients across six studies were assessed in the systematic review. The incidence of BAC on the mammogram was 10.3%. The odds or likelihood of developing CVD was higher among BAC+ women. Hypertension, hypercholesterolemia, and family history of CVD were more prevalent in BAC+ women and menopause.




Conclusion: Further studies are required to develop a semi-quantitative index of BAC for CVD screening to establish BAC as a predictor of CVD further.



Keywords: Age, breast arterial calcification, cardiovascular disease, hypertension, hypercholesterolemia, menopause

References

Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 2011; 123(4): e18-209.

Porapakkham Y, Rao C, Pattaraarchachai J, Polprasert W, Vos T, Adair T, et al. Estimated causes of death in Thailand, 2005: implications for health policy. Popul Health Metr. 2010; 8(1): 1-11.

Farmakis D, Stafylas P, Giamouzis G, Maniadakis N, Parissis J. The medical and socioeconomic burden of heart failure: a comparative delineation with cancer. International Journal of Cardiology. 2016; 203: 279-81.

Wilmot KA, O’Flaherty M, Capewell S, Ford ES, Vaccarino V. Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women. Circulation. 2015; 132(11): 997-1002.

Joseph P, Leong D, McKee M, Anand SS, Schwalm J-D, Teo K, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017; 121(6): 677-94.

Pepine CJ, Ferdinand KC, Shaw LJ, Light-McGroary KA, Shah RU, Gulati M, et al. Emergence of nonobstructive coronary artery disease: a woman’s problem and need for change in definition on angiography. J Am Coll Cardiol. 2015; 66(17): 1918-33.

EUGenMed, Group CCS, Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016; 37(1) :24-34.

Arora G, Bittner V. Chest pain characteristics and gender in the early diagnosis of acute myocardial infarction. Curr Cardiol Rep. 2015; 17(2): 1-5.

Gopalakrishnan P, Ragland MM, Tak T. Gender differences in coronary artery disease: review of diagnostic challenges and current treatment. Postgrad Med. 2009; 121(2): 60-8.

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016; 68(13): 1476-88.

Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK, et al. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 75(20): 2602-18.

Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA. 2005; 293(10): 1245-56.

Hendriks EJE, De Jong PA, van der Graaf Y, Willem PTM, van der Schouw YT, Beulens JWJ. Breast arterial calcifications: a systematic review and meta-analysis of their determinants and their association with cardiovascular events. Atherosclerosis. 2015; 239(1): 11-20.

Suh J-W, La Yun B. Breast arterial calcification: a potential surrogate marker for cardiovascular disease. J Cardiovasc Imaging. 2018; 26(3): 125-34.

Jiang X, Clark M, Singh RK, Juhn A, Schnatz PF. Association of breast arterial calcification with stroke and angiographically proven coronary artery disease: a meta-analysis. Menopause. 2015; 22(2): 136-43.

Handy CE, Quispe R, Pinto X, Blaha MJ, Blumenthal RS, Michos ED, et al. Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger. Circulation. 2018; 138(7): 727-34.

Newallo D, Meinel FG, Schoepf UJ, Baumann S, De Cecco CN, Leddy RJ, et al. Mammographic detection of breast arterial calcification as an independent predictor of coronary atherosclerotic disease in a single ethnic cohort of African American women. Atherosclerosis. 2015; 242(1): 218-21.

Rotter MA, Schnatz PF, Currier Jr AA, O’Sullivan DM. Breast arterial calcifications (BACs) found on screening mammography and their association with cardiovascular disease. Menopause. 2008; 15(2): 276-81.

Schnatz PF, Marakovits KA, O’Sullivan DM. The association of breast arterial calcification and coronary heart disease. Obstet Gynecol. 2011; 117(2): 233-41.

Kataoka M, Warren R, Luben R, Camus J, Denton E, Sala E, et al. How predictive is breast arterial calcification of cardiovascular disease and risk factors when found at screening mammography? Am J Roentgenol. 2006; 187(1): 73-80.

Iribarren C, Chandra M, Lee C, Sanchez G, Sam DL, Azamian FF, et al. Breast arterial calcification: a novel cardiovascular risk enhancer among postmenopausal women. Circ Cardiovasc Imaging. 2022; 15(3): e013526.

Iribarren C, Go AS, Tolstykh I, Sidney S, Johnston SC, Spring DB. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Women’s Heal. 2004; 13(4): 381-9.

Kemmeren JM, van Noord PAH, Beijerinck D, Fracheboud J, Banga J-D, van der Graaf Y. Arterial calcification found on breast cancer screening mammograms and cardiovascular mortality in women: the DOM project. Am J Epidemiol. 1998; 147(4): 333-41.

Abouzeid C, Bhatt D, Amin N. The top five women’s health issues in preventive cardiology. Curr Cardiovasc Risk Rep. 2018; 12(2): 1-9.

Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, et al. Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) national quality improvement initiative. J Am Coll Cardiol. 2005; 45(6): 832-7.

Atsma F, Bartelink M-LEL, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006; 13(2): 265-79.

Feng Y, Hong X, Wilker E, Li Z, Zhang W, Jin D, et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis. 2008; 196(2): 590-7.

Oshima SM, Tait SD, Fish L, Greenup RA, Grimm LJ. Primary care provider perspectives on screening mammography in older women: A qualitative study. Prev Med Reports. 2021; 22: 101380.

Silverman MG, Blaha MJ, Krumholz HM, Budoff MJ, Blankstein R, Sibley CT, et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J. 2014; 35(33): 2232-41.

Lindahl G, Rzepecki A, Dabrosin C. Increased extracellular osteopontin levels in normal human breast tissue at high risk of developing cancer and its association with inflammatory biomarkers in situ. Front Oncol. 2019; 9: 746.

Ballout RA, Remaley AT. GlycA: A new biomarker for systemic inflammation and cardiovascular disease (CVD) risk assessment. J Lab Precis Med. 2020; 5.

Yoon YE, Kim KM, Lee W, Han JS, Chun EJ, Ahn S, et al. Breast Arterial calcification is associated with the progression of coronary atherosclerosis in asymptomatic women: a preliminary retrospective cohort study. Sci Rep. 2020; 10(1): 1-9.

##plugins.themes.bootstrap3.article.details##

How to Cite
Lawson, C., Batti, P., Singh, P. ., Usman, M. S., Bashir, F., Alam, B., Asaolu, G., Abdelmalek, S. E., Sayo, B. M. J., Choga, E. S., Khan, T., Zafar, H. ., Adedoyin, A. M., Ahmed, M., & Ahmed, M. N. (2022). Breast Arterial Calcifications as A Predictor of Cardiovascular Risk: A Systematic Review. European Journal of Clinical Medicine, 3(6), 1–5. https://doi.org/10.24018/clinicmed.2022.3.6.228